SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-17-000525
Filing Date
2017-03-31
Accepted
2017-03-31 17:02:35
Documents
2
Period of Report
2017-03-29

Document Format Files

Seq Description Document Type Size
1 form3-03312017_020323.html 3  
1 form3-03312017_020323.xml 3 1670
2 ex24-03312017_020323.htm EX-24 3285
  Complete submission text file 0001415889-17-000525.txt   6363
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACADIA PHARMACEUTICALS INC. 3611 VALLEY CENTRE DRIVE,SUITE 300 SAN DIEGO CA 92130
Business Address
YANG MICHAEL J. (Reporting) CIK: 0001702283 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50768 | Film No.: 17731161